メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
第４・婦人科
病院局
岡崎医療センター
概要
フィンガープリント
研究成果
(8)
フィンガープリント
第４・婦人科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Undifferentiated Carcinoma
100%
Carcinoma Cell Lines
100%
Carcinogenicity
100%
Spinal Epidural Hematoma
100%
Endometrium
100%
Endometrial Carcinoma
100%
Past Users
75%
HMSH2
66%
Hyperplasia
66%
Microvascular Invasion
66%
Microsatellite Instability-high (MSI-H)
66%
No Significant Difference
66%
Endometrioid
66%
TP53 mutation
66%
Histological Subtypes
66%
Lymph Node Metastasis
66%
KRAS mutation
66%
HMLH1
66%
Tumor
53%
L-cells
40%
Endometrioid Carcinoma
33%
Biological Characteristics
33%
Endometrioid Adenocarcinoma
33%
Mechanisms of Carcinogenesis
33%
Protein Expression
33%
Stage III-IV
33%
Vascular Hemodynamics
33%
Progressive Paralysis
33%
Clear Cell Type
33%
Serous
33%
FIGO Stage
33%
P53 Expression
33%
Immunohistochemistry
33%
Worse Prognosis
33%
Type II Endometrial Carcinoma
33%
Loss of Expression
20%
Chromosomal Microarray
20%
New Cell Line
20%
Spindle-shaped
20%
Doubling Time
20%
Primary Tumor
20%
Aneuploidy
20%
Hormonal Treatment
20%
Older Patients
20%
E-cadherin
20%
Adhesive Behavior
20%
Histology
20%
Endometrial Biopsy
20%
Progestin
20%
Cell-cell Contact
20%
Beta-catenin
20%
Progestin Therapy
20%
SCID Mice
20%
Metastatic Lymph Node
20%
Aggressive Behavior
20%
Floating Cells
20%
Supernumerary Ovary
14%
Autoamputation
14%
Accessory Ovary
14%
Factor-free
14%
Endometrial Cancer Cell Line
14%
Endometrial Polyp
12%
Background Lesions
12%
Medicine and Dentistry
Anaplastic Carcinoma
100%
Tamoxifen
100%
Endometrium Carcinoma
100%
Carcinoma Cell Line
100%
Carcinogenicity
100%
Spinal Hematoma
100%
Endometrium
100%
Protein P53
75%
Lymph Node Metastasis
70%
Cell Line
60%
Hyperplasia
50%
Microsatellite Instability
50%
Ras Signaling
50%
Neoplasm
45%
Adenocarcinoma
25%
Endometrioid Carcinoma
25%
Clear Cell
25%
Protein Expression
25%
Carcinogenesis
25%
Immunohistochemistry
25%
Alpha Catenin
20%
SCID Mouse
20%
Primary Tumor
20%
Cell Contact
20%
Uvomorulin
20%
Gestagen
20%
Progesterone Derivative
20%
Endometrial Biopsy
20%
In Vitro
20%
Chromosome Analysis
20%
Aneuploidy
20%
Aggression
20%
Adhesive Agent
20%
Endometrial Polyp
12%
Endometrial Cancer Cell Line
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclooxygenase 2
100%
Endometrium Cancer
100%
Neoplasm
100%
COX-2 Inhibitor
100%
Etodolac
54%
Telomerase
18%
Endometrium Polyp
12%
Female Genital Tract Cancer
9%
Fibroblast Growth Factor 2
9%
Disease Free Survival
9%
Survival Rate
9%
Chemopreventive Agents
9%
Angiogenic Factor
9%
Protein P53
9%
Malignant Neoplasm
9%